[PDF][PDF] Efficacy of cetuximab combined with chemotherapy in 53 patients with advanced colorectal cancer
GF Guo, LP Xia, B Zhang, WQ Jiang, MZ Liu… - … J Cancer, 2009 - scholar.archive.org
… highly differentiated cancer, 34 had moderately differentiated … Cetuximab was used once
a week until disease progression, … (EGFR) was a target for antitumor treatment. Not only was …
a week until disease progression, … (EGFR) was a target for antitumor treatment. Not only was …
[PDF][PDF] OCT4 expression in hepatocellular carcinoma and its clinical significance
PZ Huang, CL Lu, BK Li, J Hong, L Huang, L Wang… - … J Cancer, 2010 - researchgate.net
… Tissue samples were stored at 80益 after treatment with … degree of differentiation of HCC
while it was related to liver tumor size… tumor progression and regulates motility of bladder cancer …
while it was related to liver tumor size… tumor progression and regulates motility of bladder cancer …
[PDF][PDF] Multi-Target Study of Osteosarcoma Based on Microarray Analysis
Z Liu, X Zhou, T Lin, L Cheng - Hans J. Biomed, 2019 - pdf.hanspub.org
… the treatment of osteosarcoma; therefore, multi-target therapy is … Finally, multiple targets
were identified based on these … search for the relationship between differential genes and the …
were identified based on these … search for the relationship between differential genes and the …
[PDF][PDF] Expressions of SNCG in gastric adenocarcinoma and its clinical significances
SHI Li-fang, Z Shu-fang2A, Z Yong-gang… - Prog Mod …, 2011 - biomed.cnjournals.com
… progression and metastasis of gastric adenocarcinoma and serve as target spots in the
targeted therapy … 31 were well or moderately differentiated adenocarcinoma and 59 were poorly …
targeted therapy … 31 were well or moderately differentiated adenocarcinoma and 59 were poorly …
[PDF][PDF] Radiomics in predicting tumor molecular marker P63 for non-small cell lung cancer
Q Gu, Z Feng, X Hu, M Ma, MM Jumbe… - Zhong Nan Da Xue …, 2019 - researchgate.net
… the well differentiated squamous epithelial tumors and adenocarcinoma, but … Accordingly,
the goal of this study is to … As we know, recent advancement in the therapy for lung cancer is …
the goal of this study is to … As we know, recent advancement in the therapy for lung cancer is …
[PDF][PDF] C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines
PY Huang, MH Hong, X Zhang, HQ Mai, DH Luo… - … J Cancer, 2010 - researchgate.net
… the regulation of tumor cell proliferation, differentiation, adhesion, … of effective treatment,
and the rates of treatment effectiveness … STI571 inhibits small cell lung cancer growth [J]. Clin …
and the rates of treatment effectiveness … STI571 inhibits small cell lung cancer growth [J]. Clin …
[PDF][PDF] Comparative proteomic approach in differentiating multicentric occurrence and intrahepatic metastasis in multinodular hepatocellular carcinomas
M Su, LQ Li, T Peng, Y Guo, KY Xiao, LM Shang… - … J Cancer, 2010 - scholar.archive.org
… for molecular markers and therapeutic targets of clinical … strategy to screen for differential
protein expression profiles … carcinoma: association with tumor progression as determined by …
protein expression profiles … carcinoma: association with tumor progression as determined by …
[PDF][PDF] Intervention of riboflavin metabolism improves sensitivity of ovarian cancer HO8910 cells to cisplatin in vitro
RH Yang, Y Song, SQ Wu… - Chin J Pharmacol …, 2016 - cjpt.magtechjournal.com
… In the process of cancer treatment,cell apoptosis induced by … proliferation ability and
differentiation potential. CSCs are the … an important target in the chemotherapy of ovarian …
differentiation potential. CSCs are the … an important target in the chemotherapy of ovarian …
[PDF][PDF] Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance
XL Chen, SX Yuan, C Chen, YX Mao, G Xu… - Ai Zheng, 2009 - scholar.archive.org
… , tumor progression was diagnosed. RFS referred to the interval between tumor resection and
the date of tumor progression … therapy could provide a new target for pancreatic carcinoma …
the date of tumor progression … therapy could provide a new target for pancreatic carcinoma …
Mechanism of Fuzheng Kang'ai Formula (扶正抗癌方) Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
Y Tian, S Fu, B Li, L Yuan, Z Bing - Chinese journal of integrative medicine, 2022 - Springer
… critical role in tumor growth, progression, and … target genes of FZKA for LUAD by matching
the target genes related to drug and disease treatment with differential genes related to tumor …
the target genes related to drug and disease treatment with differential genes related to tumor …